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Abstract The aim of this study was to investigate the effects of transplanted Wharton’s
jelly mesenchymal stem cells (WJMSCs) of caprine umbilical cord on cutaneous wound
healing process in goat. After collection of caprine pregnant uterus of mixed breed goats
from abattoir, the Wharton’s jelly (WJ) of umbilical cord was harvested. The tissues were
minced in ventilated flasks and explant culture method was used for separating
mesenchymal stem cells (MSCs). The isolated cells were immunostained for Actin protein,
histochemically assayed for the presence of alkaline phosphatase activity, and analyzed for
detection of matrix receptors (CD44) and hematopoetic lineage markers (CD34), using flow
cytometery. After The isolated cells, 3×106 MSCs were stained with BrdU and prepared for
transplantation to each wound. Four 3-cm linear full thickness skin incisions were made on
both sides of thoracic vertebrate of four Raeini goats (two wounds on each side). The left
wounds were implanted with MSCs in 0.6 ml of Phosphate buffer saline (PBS), and the
right wounds considered as control group that received 0.6 ml of PBS. The samples were
taken from the wounds 7 and 12 days after the wounding, and healing process was
compared histologically between the two groups. Anti-BrdU staining showed that the
transplanted cells were still alive in the wound bed during the study. The histopathological
study revealed that re-epithelialization was complete at days 7 in treated wounds with
WJMSCs, whereas in control wound the wounds still showed incomplete epithelialization
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12 days after wounding. Also, microscopic evaluation showed less inflammation, thinner
granulation tissue formation with minimum scar in the treated wounds in comparison with
control wounds. In conclusion, this study demonstrates the beneficial effect of caprine
WJMSCs in cutaneous wound healing in goat.
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Introduction
Optimum healing of cutaneous wound requires a well-orchestrated integration of the
complex biological and molecular events of cell migration and proliferation and
extracellular matrix deposition, angiogenesis and remodeling. However, this orderly
progression of healing process is impaired in many chronic diseases (Wu et al. 2007).
Recent reports describing the plasticity of stem cells may herald a new era in the treatment
of many disorders (Badiavas and Falanga 2003). Mesenchymal stem cells (MSCs) have
shown a strong propensity to ameliorate tissue damage in response to injury and disease
(Phinney and Prockop 2007). MSCs have demonstrated efficacy as therapeutic vectors in
animal models of skeletal defects (Horwitz et al. 2002), lung injury (Ortiz et al. 2007),
kidney disease (Kunter et al. 2006), diabetes (Lee et al. 2006), myocardial infarction
(Minguell and Erices 2006) and various neurogical disorders (Phinney and Isakova 2005).
It is well established that MSCs produce a variety of cytokines and adhesion molecules that
regulate aspects of hematopoiesis. Additionally, MSCs express transcripts encoding
proteins that regulate a broad range of biological activities, including angiogenesis, wound
healing, immunity, and defense as well as neural activities. MSCs promote tissue repair by
secretion of factors that enhance regeneration of injured cells, stimulate proliferation and
differentiation, decrease inflammatory and immune reactions. Therefore, the ability of
such cells to alter the tissue microenvironment may contribute more significantly than
their capacity for transdifferentiation in effecting tissue repair (Phinney and Prockop
2007). In the most pervious studies, MSCs that were used to treat skin defects were
isolated from bone marrow (Sasaki et al. 2008; Wu et al. 2007; Badiavas and Falanga
2003; Stepanovic et al. 2003; Phinney and Prockop 2007). These reports have revealed
that stem/progenitor cells, particularly those derived from bone marrow, significantly
promote wound healing process (Phinney and Prockop 2007). Recently, it has been shown
that topical administration of human umbilical cord blood MSCs in the cutaneous wound
of normal (Luo et al. 2010) and diabetic mice (Tark et al. 2010) had a positive effect on
wound healing.
Recent studies have indicated other source of MSCs in Wharton’s jelly, a gelatinous
connective tissue from umbilical cord (Mitchell et al. 2003). Wharton’s jelly Mesenchymal
cells possess stem cell properties. These cells could be induced to differentiate into
osteogenic, chondrogenic, adipogenic, myogenic, and neuron like cells in vitro. It has also
been found that the transformed human MSCs of Wharton’s jelly (WJMSCs) survive in
different organs of rat after transplantation without the need for immunological suppression,
suggesting that WJMSCs might be a good stem cell source for transplantation (Yang et al.
2008). Although there are a lot of studies about positive effects of transplanted stem cells
on cutaneous wound healing, to the authors’ knowledge, there is no documented data about
the role of WJMSCs as a new source of stem cells on skin wound’s repair. In this study, the
effects of transplantation of WJMSCs of caprine umbilical cord on first intention cutaneous
wound healing in goat were evaluated.
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Material and methods
All experimental protocols were approved by the Research Ethic Committee of the Kerman
Neuroscience Research Center of Kerman, Iran. All chemicals except those otherwise
indicated were purchased from Sigma-Aldrich Company (St. Louis, MO, USA).
Isolation and culture of MSCs from caprine Wharton’s jelly
WJMSCs of caprine umbilical cord were isolated using the method described previously by
Babaei et al. (2008). Briefly, Four Uteri of pregnant mixed goats, in last two months of
pregnancy, were collected from abattoir and transported within two hours to the laboratory.
Umbilical cords were obtained from the late-gestation fetuses and placed in sterile
phosphate buffer saline (PBS, composition in mM: 140 NaCl; 2 KCl; 1.5 KH2PO4; 15
Na2HPO4) supplemented with 2 μg/mL amphotericin B (Bristol-Myers Squibb), 200 IU/mL
penicillin and 200 μg/mL streptomycin. Umbilical cord segments, 5 cm long, were cut
longitudinally and then, the umbilical cord artery and veins were wiped off. The
Wharton’s Jelly of umbilical cord was cut into 2×2 mm2 segments. 8–10 segments were
transferred to each 35 mm disposable Falcon culture dish (Becton Dickinson & Company
Franklin lakes) containing 1 mL of cell culture medium (α-MEM; Alpha modification of
Minimum Essential Medium Eagle) supplemented with 20% fetal bovine serum (FBS,
Gibco), 2 μg/mL amphotericin B, 200 IU/mL penicillin, and 200 μg/mL streptomycin and
maintained at 37°C in a humidified atmosphere of 5% CO2. Adherent Wharton’s jelly
fragments were observed 24 h after plating and their cell culture mediums was filled up to
3 mL. Jelly explants were removed from dish cultures 5 days after plating and the
adherent cells were cultured for at least 5 more days and the medium was refreshed every
72 h. The adhered cells were dissociated with 0.5 g/l trypsin+1.0 mM EDTA in PBS.
Cells were subcultured in a 250 mL Falcon flask (Becton Dickinson & Company Franklin
lakes) and denoted as passage 1.
Immunocytochemistry
Isolated Wharton’s jelly cells were immunostained for detection of α-SMA (mouse
monoclonal Clone 1A4; Sigma, A2547) in their cytoplasms. Isolated cells were seeded over
a glass slide and allowed to grow up to 48 h. After culturing, growth medium was removed
and slides were washed with PBS and were fixed in 4% paraformaldehyde for 5 min at 4°C.
After a subsequent rinse with PBS, slides were blocked with 10% normal goat serum for
30 min in humidified chamber at room temperature and washed with PBS. Then the slides
were incubated with primary antibody for 60 min, washed three times with PBS and incubated
with the secondary antibody (goat anti-mouse IgG conjugated to horseradishperoxidase) for
60 min at room temperature. Afterwards, the cells were stained with 3,3’-diaminobenzidine
(DAB) and the brown precipitate product was considered as a positive reaction to α-SMA.
Then images were taken by an inverted microscope (Olympus, IX71, Japan) equipped with a
digital color camera (DP72, Olympus, Japan).
Alkaline phosphatase assay
The method of Alkaline phosphatase (AP) Assay has been described in the previous study
by Babaei et al. (2008). Briefly, the isolated cells were grown on a 35 mm culture dish for
several days until colony formation and the medium was refreshed every 72 h. AP activity
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was detected by using an AP Kit (Sigma-Aldrich Chemie GmbH, Germany, Catalog No. 86-1)
according to the manufactures instruction. A dark red reaction product following 15 min of
exposure to alkaline dye mixture confirmed AP activity. As a positive control, a blood smear
from patient with pyogenic leukocytosis was prepared and stained.
Flow cytometry
The isolated cells were prepared at a concentration of 1×105 cells/ml in MEM with 10%
FBS incubated for 15 min at 4°C with a 1:9 dilution of normal goat serum in PBS to block
nonspecific binding of the primary antibody. Then cells were labeled with antibodies
against FITC-conjugated anti-CD44 and FITC-conjugated anti-CD34 (Chemicon; USA) for
one hour. The cells were washed with 2% FBS in PBS. Cells were acquired using FACS
Calibur (BD = Becton Dickinson, USA) and analyzed using WinMDI Cell Quest Software
(BD Biosciences, USA).
Labeling and preparation of cells for transplantation to the wound
For tracking the transplanted cells in the skin wounds, the cells were prelabeled with
bromodeoxyuridine (BrdU; Chemicon-Millipore, Temecula, CA) before the transplantation
was carried out. Briefly, the stem cells were incubated with 10 μM of BrdU in the culture
medium for 48 h in a humidified 37°C incubator with 5% CO2 in the air. To evaluate the
efficacy of BrdU incorporation, the treated cells were incubated with 2 N HCl for 30 min.
followed by incubation with the primary antibody against BrdU (abcam, USA, 1:40)
overnight at 4°C. The cells were then washed three times in PBS and were incubated with
fluorescent Alexa-fluor® 647 goat anti-mouse secondary antibody (Molecular probes, USA,
1:400)
After characterization and labeling of the mesenchymal cells isolated from the caprine
Wharton’s jelly, 3×106 live cells in 600 μl PBS was prepared to transplant to each wound.
Animals and wound model
Four adult male Raeini goats with body weights ranging from 18.5–22 kg were used in the
trial. The animals were housed in a goat pen and maintained on grass (hay) supplemented
with concentrate. Drinkable water was made freely available. Just before the commence-
ment of the experiment, the goats were judged to be in good health based on clinical and
hematological evaluation. Four wounds were designed for each goat, two wounds on each
side of the midline on dorsal surface of the back region.
The goats were sedated by Intramuscular administration of Xylazine hydrochloride,
0.05 mg/kg, and then placed on dorsal recumbency. In brief, after hair removal from the
dorsal surface of thoracic regions, surgical sites were prepared aseptically for the wounding.
Four 3-cm linear full thickness cutaneous incisional wounds were created on the dorsal part
of thoracic region, on both sides. After accurate hemostasis, cell injections were carried out
in the wounds. In this study, left wounds were considered as a treatment group, received 3
million cells in 600 μl PBS, and right wounds received only 600 μl PBS, without any cells.
The mesenchymal cells and/or PBS were injected intradermally around the wound at three
injection sites and also subcuticulary in wound bed at three injection sites (the total volume
of six injections was 600 μl per wound). After cell transplantation, the wounds were
sutured with 3–0 nylon (Naylon, Tebkeihan, Iran) in a simple interrupted pattern. All
wounds were closed with two sutures.
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Histological examination
For microscopic studies of wound healing process, tissue specimens were taken 7 and
12 days after surgery, from the cranial and caudal wounds, respectively, in both sides.
The obtained samples from the wound beds and underlying tissue surrounded by
margin of normal skin were fixed in 10% buffered formalin. The samples were
embedded in paraffin, sectioned at 4 μm, and stained with hematoxylin and eosin
(H&E) for light microscopy. Histological study was in a blinded fashion. Each slide
was evaluated for re-epithelialization, dermal cellularity, granulation tissue formation
and angiogenesis.
To identify the transplanted cells in wound bed, Four-μm thick slices were deparaffined
by standard procedure and then treated with 2 N HCL for 30 min at room temperature. The
samples were incubated with the primary antibody against BrdU (abcam, USA, 1:40)
overnight at 4°C. After several washing with PBS, the samples were incubated with
fluorescent Alexa-fluor® 647 goat anti-mouse secondary antibody (Molecular probes, USA,
1:400) for 1 h. After three washes in PBS, the slides were mounted with glycerol and the
images were taken by an Olympus IX71 inverted fluorescent microscope equipped with a
DP72 digital color camera (Olympus, Japan).
Results
Characterization of MSCs of caprine Wharton’s jelly
Most of isolated cells from caprine Wharton’s jelly matrix explants displayed fusiform or
spindle-form cells with a prominent nucleus and extensive cytoplasmic processes. These
cells reached a good confluency after about 10 days so they were subcultured and
considered as passage one. Confluent cells were arranged in parallel arrays. As Wharton’s
jelly cells reached considerable confluency, colonies of cells began to form (Fig. 1).
Immunocytochemical analysis was performed to test the expression of Actin protein.
Cells with brown filaments in cytoplasm were considered as α-SMA Positive cells. (Fig. 2).
In the current study, isolated cell colonies formed in the culture exhibited positive AP
activity. The reaction was very intense at the border of colonies.
Flow cytometry analysis of WJMSCs showed that they were negative for CD34 and
positive for CD44 (Fig. 3).
Microscopic study
To identify transplanted WJMSCs in the wound, the cells were prelabeled with BrdU. In
our pilot study, bromodeoxyruidine staining of MSCs demonstrated that nearly 80% of cells
were labeled with BrdU. The transplanted MSCs were localized within the granulation
tissue that was confirmed by means of immunohistochemical staining with monoclonal
antibodies against BrdU (Fig. 4).
Histopathological evaluation of wounds on day 7, disclosed enhanced re-epithelialization in
MSCs-treated wounds (complete epithelialization in all 4 treated wounds) in comparison
with wounds in control group (incomplete epithelialization in all 4 non-treated wounds).
Inflammatory cell infiltration in non-treated wounds was more severe than the treated
wounds. Unlike treated wounds, ulcer was observed in all non-treated wounds
obviously (Figs. 5 and 6).
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On day 12, in non-treated wounds, more but incomplete re-epithelialization and thick
granulation tissue was observed (Fig. 7), whereas, in treated wounds intact skin with
complete re-epithelialization, no inflammation, and thin granulation tissue were seen.
Totally, histopathological study clearly confirmed that the wound healing process in non-
treated wounds was significantly in earlier phases compared with the WJMSCs-treated
wounds.
According to the microscopic study, transplanted WJMSCs survived in the cutaneous
wound bed and significantly promoted healing process.
Discussion
The present study investigates the efficacy of transplantation of mesenchymal stem cells
that were isolated from caprine Wharton’s jelly on incisional cutaneous wound healing in
goats. In recent years, great successes have been achieved in accelerating the capacity for
wound healing. Several studies have indicated a contribution of MSCs to reconstituting skin
Fig. 1 Spindle-form cells with
prominent nucleus that isolated
from Wharton’s jelly explants
(arrow). The isolated cells formed
colony (arrow head). Scale bar=
25 μm
Fig. 2 Immunocytochemical
staining against Actin protein in
Wharton’s jelly fibroblast like
cells. Arrows show sample of
cells with brown color in cyto-
plasm which are positive due to
actin protein. Scale bar=30 μm
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in cutaneous wounds (Fu and Li 2009). Animal transplantation studies have shown that
MSCs are able to differentiate into cells of the residing tissue, repair tissue damaged by
trauma or disease and partially restore normal function. (Yoshikawa et al. 2008; Sasaki et al.
2008) MSCs not only participate in the regeneration of tissue of mesenchymal lineage such
as intervertebral disc cartilage (Crevensten et al. 2004), bone (Arinzeh et al. 2003), and
Fig. 4 Cutaneous wound injection site stained for 5-bromo-2-deoxyuridine at 1 week after intradermal and
subcuticular injection of mesenchymal cells. 5-Bromo-2-deoxyruidine–positive transplanted mesenchymal
cells (Red color) are dispersed in the scar area. Hematoxylin. Scale bar=100 μm
Fig. 3 Flow cytometric analysis
of surface-marker expression on
Wharton’s jellies mesenchymal
stem cells. Notice that the
isolated cells are positive for
CD44 and negative for CD34
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cardiomyocytes (Fukuda 2002), but also appear to differentiate into cells derived from other
embryonic layers, including skin (Sasaki et al. 2008). In the most pervious studies, MSCs
were isolated from bone marrow and other tissue such as adipose tissue, nerve tissue,
umbilical cord blood and dermis (Kim et al. 2007; Dai et al. 2007; Perng et al. 2006; Shih et
al. 2005; Jones et al. 2002; Luo et al. 2010; Tark et al. 2010). These experiments
demonstrated the plasticity of MSCs and their potential usefulness in complex tissue repair
and regeneration and in cell therapy (Fu and Li 2009).
In the current study, MSCs were isolated from Wharton’s jelly of caprine umbilical cord.
The Wharton’s jelly of the umbilical cord contains mucoid connective tissue and fibroblast
like cells (Wang et al. 2004). In pervious studies Wharton’s jelly cells were successfully
isolated from human and procaine umbilical cord tissue and explanted as primary culture
(Mitchell et al. 2003; Wang et al. 2004). It has been confirmed that multipotent MSCs exist
in the Wharton’s jelly of the human umbilical cord and can be isolated easily (Meyer et al.
2008). Mesenchymal stromal cells isolated from Wharton’s jelly have been induced to form
bone, cartilage, adipose, and neuron-like cells (Troyer and Weiss 2008; Yang et al. 2008).
In a preliminary study, Babaei isolated MSCs from Wharton’s jelly of caprine umbilical
Fig. 5 Complete re-
epithelialization in treatment
group, 7 days after cell
transplantation. hematoxylin and
eosin. Scale bar=200 μm
Fig. 6 Incomplete re-
epithelialization in control group,
7 days after wounding.
Hematoxylin and eosin. Scale
bar=250 μm
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cord. He stated that the isolated cells from Wharton’s jelly show stem cells behaviors
(Babaei et al. 2008).
The morphology of the heterogenous population of Wharton’s jelly cells isolated from
explants included, mesenchymal-like cells with a fusiform or stellete appearance and
individual round cells. The cells are able to form colonies after confluency stage in dish
culture (Mitchell et al. 2003). The Wharton’s jelly contains colony-stimulating activity and
growth factors IGF-1, EGF and TGFα (Wang et al. 2004). The classical assay used to
identify MSCs is the colony forming unit assay that identifies adherent spindle shaped cells
that proliferate to form colonies (Sasaki et al. 2008). Wharton’s jelly was shown to be
composed of smooth-muscle-actin-positive and myofibroblast-like stromal cells (Kobayashi
et al. 1998; Mitchell et al. 2003). Another nonspecific test for approving stem cells is
expression of AP enzyme. AP is an enzyme that is long-known to be expressed in
embryonic stem cells as well as primordial germ cells (MacGregor et al. 1995). In the
pervious study, Babaei et al. (2008) showed that colonies formed by WJMSCs of caprine
umbilical cord exhibited AP activity in vitro. In an in vitro study, AP activity was also
detected in matrix cells colonies of pig umbilical cord (Carlin et al. 2006).
Base on the flow cytometric analysis to determine various superficial cell markers in
human MSCs isolated from Wharton’s jelly, it has been suggested that these stromal cells
are similar to MSCs. Human MSCs of Wharton’s jelly express matrix receptors CD44 but
not hematopoietic lineage marker CD34 (Wang et al. 2004; Troyer and Weiss 2008). It has
been stated that canine bone marrow-derived mesenchymal stem cells were positive for
CD44 and negative for CD34. The negative results obtained for CD34 demonstrated that
cells of hematopoietic origin were excluded during the WJMSC culture. The positive
results obtained for CD44 emphasized that the isolated cells were MSCS (Jung et al. 2009).
In the present study, based on the cells characteristics and behaviors in culture medium and
also according to the imunohistochemical staining and flow cytometric analysis, the isolated
mesenchymal cells from caprine Wharton’s jelly were mesenchymal stem cells. The isolated
cells in our study were fusiform or spindle-form cells and were able to form cell colony in
culture. These cells showed a positive reaction to immunohistochemical staining of α-actin
smooth muscle and alkaline phosphate. The flow cytometric analysis showed that some of the
isolated cells were positive for CD44 and most of them were negative for CD34.
The Wharton’s jelly cells are non-immunogenic on the first injection into the allogenic
recipients. However, repeated injection of Wharton’s jelly Cells produced an immunogenic
Fig. 7 Incomplete re-
epithelialization in control
group, 12 days after wounding.
Hematoxylin and eosin.
Scale bar=250 μm
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response (Troyer and Weiss 2008). In this study we used allogenic WJMSCs transplan-
tation; donors were mixed breed goats and recipients were Raeini goats, and the BrdU
staining of labeled cells confirmed that the transplanted cells were still present in the wound
bed. To date, there is no research about the effects of MSCs of Wharton’s jelly on cutaneous
wound healing, but the beneficial effects of this type of MSCs were approved in various
experimental disorders. Yang’s revealed the beneficial effects of human MSCs isolated from
Wharton’s jelly after complete transaction of the rat spinal cord. He stated that transplanted
cells promote the regeneration of corticospinal fibers and locomotors recovery in the rat. He
also stated that the transformed Human WJMSCs in the rat were still viable 4 months after
transplantation without need for immunological suppression, suggesting that these cells
might be a good stem cell source for transplantation (Yang et al. 2008). Lund et al. (2007))
administered WJ-Cs into the eyes of a rodent model of retinal disease. They reported that
the WJ-Cs exhibited the best histological evidence of photoreceptor rescue (Lund et al.
2007). Human WJ-Cs ameliorates apomorphine-induced behavioral deficits in a hemi-
parkinsonian rat model (Weiss et al. 2006). In other studies the positive effects of WJ-MSC
for treatment of stroke (Borlongan et al. 2004) or myocardial infarction (Grinnemo et al.
2004) were confirmed.
A lot of studies confirmed those bone marrows MSCs are useful in cutaneous wound
healing process. Bone marrow MSCs repair epithelium in vitro through differentiation and
fusion (Spees et al. 2003). It has been demonstrated that MSCs prompted cutaneous wound
repair via differentiation into multiple skin cell types including; keratinocytes, endothelial
cells, pericytes, and monocytes (Sasaki et al. 2008). Wu suggested that bone marrow
engrafted in cutaneous wound of diabetic rat completed re-epithelialization after 7 days
(Wu et al. 2007). MSCs have also been reported to differentiate into various epithelial cell
types such as; skin epithelial cells, after systemic administration in vivo (Nakagawa et al.
2005). Luo et al. (2010) showed that human umbilical cord MSCs could differentiate into
keratinocyte in the cutaneous wound tissue of mice, when it was administered locally on the
fresh wounds (Luo et al. 2010). Our study showed that epithelialization was complete on
day 7 or earlier in the treated wounds with WJMSCs, whereas in the control wound
(without treatment), the wounds still showed incomplete epithelialization 12 days after
wounding. Also microscopic evaluation showed minimum inflammation and thin
granulation tissue formation with minimum scar in the MSCs treated wounds, which
indicates a better wound healing process in the treatment group.
In conclusion, this study demonstrates the beneficial effect of caprine WJMSCs in
cutaneous wound healing in goat. Administration of WJMSCs may present novel
therapeutic methods in the treatment of cutaneous wound, especially in chronic wounds
and other conditions.
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